Fairmount Healthcare Fund II L.P. - Director at Spyre Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
SYRE on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Fairmount Healthcare Fund II L.P. in Spyre Therapeutics, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-4,684,781
Avg price
$85.31
Total value
-$399,658,667

Net

Past year
Shares
-4,684,781
Share %
-100%
Total value
-$399,658,667

Transaction history for Fairmount Healthcare Fund II L.P. in Spyre Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .